Evidence map›Paper›PMID 40294889›Full record

ArticleJournal of chemical information and modeling2025

Synthon-Based Strategies Exploiting Molecular Similarity and Protein-Ligand Interactions for Efficient Screening of Ultra-Large Chemical Libraries.

Brian Medel-Lacruz, Albert Herrero, Fernando Martín, Enric Herrero, F Javier Luque, Javier Vázquez

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brian Medel-LacruzResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain and Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), 08003 Barcelona, Spain.
Albert HerreroPharmacelera, Parc Científic de Barcelona (PCB), 08028 Barcelona, Spain.ORCID 0000-0001-9780-2701
Fernando MartínPharmacelera, Parc Científic de Barcelona (PCB), 08028 Barcelona, Spain.ORCID 0009-0004-4776-3491
Enric HerreroPharmacelera, Parc Científic de Barcelona (PCB), 08028 Barcelona, Spain.ORCID 0000-0001-7837-3593
F Javier LuqueDepartament de Nutrició, Cieǹcies de l'Alimentació i Gastronomia, Facultat de Farmàcia i Cieǹcies de l'Alimentació, Institut de Biomedicina (IBUB) and Institut de Química Teòrica i Computacional (IQTCUB), Santa Coloma de Gramenet, 08921 Barcelona, Spain.ORCID 0000-0002-8049-3567
Javier VázquezPharmacelera, Parc Científic de Barcelona (PCB), 08028 Barcelona, Spain.ORCID 0000-0003-4400-6378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid expansion of ultralarge chemical libraries has revolutionized drug discovery, providing access to billions of compounds. However, this growth poses relevant challenges for traditional virtual screening (VS) methods. To address these limitations, synthon-based approaches have emerged as scalable alternatives, exploiting combinatorial chemistry principles to prioritize building blocks over enumerated molecules. In this work, we present exaScreen and exaDock, two novel synthon-based methodologies designed for ligand-based and structure-based VS, respectively. In the former case, synthon selection is guided by the 3D hydrophobic/philic distribution pattern in conjunction with a specific synthon alignment protocol based on a quadrupolar expansion over the atoms that participate in the linking bonds between fragments. On the other hand, accommodation to the binding site under a geometrically restrained docking of synthon-based hybrid compounds is used in the selection of the optimal synthon combinations. These strategies exhibit comparable performance to the search performed using fully enumerated libraries in identifying active compounds with significantly lower computational cost, offering computationally efficient strategies for VS in ultralarge chemical spaces.

Indexed as

ProteinsSmall Molecule LibrariesBinding SitesDrug DiscoveryDrug Evaluation, PreclinicalLigandsMolecular Docking SimulationProtein BindingLigandsProteinsSmall Molecule Libraries

Identifiers

PMID40294889
PMCPMC12309548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.